Quarterly report pursuant to Section 13 or 15(d)

LOSS PER SHARE

v3.7.0.1
LOSS PER SHARE
9 Months Ended
Jun. 30, 2017
Earnings Per Share [Abstract]  
LOSS PER SHARE
  5. LOSS PER SHARE

 

In accordance with ASC 260-10 (formerly SFAS 128, “Computation of Earnings Per Share”), basic net income (loss) per share is computed by dividing the net income (loss) to common stockholders for the period by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of common and dilutive common equivalent shares outstanding during the period.  For the three-month and nine-month periods ended June 30, 2017 and 2016, the Company has excluded all common equivalent shares from the calculation of diluted net loss per share as such securities are anti-dilutive. 

 

A summary of the net income (loss) and shares used to compute net income (loss) per share for the three-month and nine-month periods ended June 30, 2017 and 2016 is as follows:

 

    Three months ended
June 30,
 
    2017     2016  
Net Loss for computation of basic and diluted net loss per share:            
Net loss   $ (1,572,400 )   $ (1,354,400 )
Basic and Diluted net loss per share:                
Basic net loss per share   $ (0.62 )   $ (2.53 )
                 
Basic and Diluted weighted average shares outstanding     2,535,394       535,805  
                 
Anti-dilutive common equivalent shares not included in the computation of dilutive net loss per share:                
Convertible debt     -       493,618  
Warrants     6,895       490,733  
Options     353,145       78,944  

 

    Nine months ended
June 30,
 
    2017     2016  
Net Loss for computation of basic and diluted net loss per share:            
Net loss   $ (4,464,600 )   $ (4,948,400 )
Basic and Diluted net loss per share:                
Basic net loss per share   $ (1.91 )   $ (9.50 )
                 
Basic and Diluted weighted average shares outstanding     2,336,283       520,412  
                 
Anti-dilutive common equivalent shares not included in the computation of dilutive net loss per share:                
Convertible debt     -       408,653  
Warrants     7,027       309,768  
Options     337,559       73,747